Please ensure Javascript is enabled for purposes of website accessibility

Aurora Cannabis Pops After Hours on Second-Quarter Results

By Eric Volkman - Updated Feb 12, 2021 at 6:54AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company showed encouraging growth in the stronger of its two main product categories.

Aurora Cannabis (ACB -3.62%) was lively in after-hours trading on Thursday, following release of its second-quarter 2021 figures following market close.

The high-profile Canadian marijuana company's net revenue for the period was just under 67.7 million Canadian dollars ($53.3 million), which was down marginally from the previous quarter's results, but 23% higher on a year-over-year basis. 

Meanwhile, the comprehensive net loss came in at nearly CA$302 million ($238 million), or CA$1.74 ($1.37) per share. This put it between the first-quarter shortfall of CA$106 million ($83 million) and the CA$1.3 billion ($1.0 million) of the year-ago quarter.

Gloved hand holding marijuana leaf in front of Canadian flag.

Image source: Getty Images.

Encouragingly, both of Aurora's main product categories -- recreational marijuana and medical product -- saw healthy annual rises. For the former, this was 25%, helped by a CA$1.7 million ($1.3 million) sequential improvement in the sale of derivatives such as edibles and vapes.

The medical segment, the larger of the two in terms of sales for the company, grew 42%. This is particularly heartening given that medical cannabis has significantly higher margins than its recreational counterpart. International sales were the fuel that lit the rocket, as a growing market abroad boosted Aurora's medical take by 562%.

The company didn't hesitate to point out that its use of cash has fallen dramatically, with a 74% year-over-year chop to CA$70.5 million ($55.5 million) for the quarter. At the end of the period, it had CA$565 million ($445 million) in cash on its books.

In early after-hours trading Thursday, Aurora stock was up by more than 8%, well ahead of the gain in the S&P 500 during standard market hours.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Stock Quote
Aurora Cannabis
$2.93 (-3.62%) $0.11

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/20/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.